Registration
CORNERSTONE GOVERNMENT AFFAIRS, INC. for BIONTECH US INC.
Client
Income
—
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
Issues impacting development of immunotherapies and optimizing use of mRNA technology.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANTHONY LAZARSKI New | Senior Legislative Advisor, Senate Member Office (Inhofe); Professional Staff Member, Senate Armed Services Committee; Military Legislative Assistant, Senate Member Office (Inhofe) |
| WENDY SAMMONS-JACKSON New | Director, Military Infectious Diseases Research Program, US Army Medical Research and Development Command |
| MICHAEL SMITH New | — |
| SUSAN SWEAT New | LC, LA & LD House Office (Wicker); LD Senate Member Office (Wicker) |
Health Issues HCR
Issues impacting development of immunotherapies and optimizing use of mRNA technology.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANTHONY LAZARSKI New | Senior Legislative Advisor, Senate Member Office (Inhofe); Professional Staff Member, Senate Armed Services Committee; Military Legislative Assistant, Senate Member Office (Inhofe) |
| WENDY SAMMONS-JACKSON New | Director, Military Infectious Diseases Research Program, US Army Medical Research and Development Command |
| MICHAEL SMITH New | — |
| SUSAN SWEAT New | LC, LA & LD House Office (Wicker); LD Senate Member Office (Wicker) |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| BIONTECH SE | Germany | Germany | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.